U.S. Supreme Court Decision Shields Generic Drug Manufacturers
In its 5-4 decision filed on June 24, 2013, the Supreme Court of the United States (“Supreme Court”) held that personal injury claims against generic drug manufacturers under design-defect consumer protection state laws that turn on the adequacy of a drug’s warnings are pre-empted [...]